Results 1 to 10 of about 30,644 (144)

Intranasal delivery systems for traumatic brain injury: Advancements and perspectives [PDF]

open access: yesJournal of Tissue Engineering
Traumatic brain injury (TBI) is a major cause of mortality and morbidity, commonly leading to long-term impairments in cognition, sensorimotor function, and personality. While neuroprotective drugs have demonstrated some efficacy in vitro cultures and in
Shin Hyuk Yoo   +5 more
doaj   +2 more sources

Intranasal Delivery of Ketamine Induces Cortical Disinhibition. [PDF]

open access: yeseNeuro, 2023
Our previous studies find that subcutaneously administered (s.c.) subanesthetic ketamine promotes sustained cortical disinhibition and plasticity in adult mouse binocular visual cortex (bV1). We hypothesized that intranasal delivery (i.n.) of subanesthetic ketamine may have similar actions.
Qiao X   +4 more
europepmc   +5 more sources

Intranasal delivery of rotigotine to the brain for treating Parkinson’s disease [PDF]

open access: yesFundamental Research
: The development of sustainable and non-invasive method for delivering drugs to the brain is crucial for the effective treatment of Parkinson’s disease (PD).
Dandan Kou   +6 more
doaj   +2 more sources

Intranasal delivery of a subunit protein vaccine provides protective immunity against JN.1 and XBB-lineage variants [PDF]

open access: yesSignal Transduction and Targeted Therapy
The mucosal immune response plays a crucial role in the prevention of respiratory viruses. Given the risk of recurrent SARS-CoV-2 infections in the population, the rapid development of next-generation intranasal COVID-19 vaccines with high safety and ...
Hong Lei   +38 more
doaj   +2 more sources

Rapid and Widespread Distribution of Intranasal Small Extracellular Vesicles Derived from Mesenchymal Stem Cells throughout the Brain Potentially via the Perivascular Pathway

open access: yesPharmaceutics, 2023
Intranasal administration is a promising strategy to enhance the delivery of the sEVsomes-based drug delivery system to the central nervous system (CNS).
Weiwei Shen   +5 more
doaj   +1 more source

Differential Biodistribution of Adenoviral-Vectored Vaccine Following Intranasal and Endotracheal Deliveries Leads to Different Immune Outcomes

open access: yesFrontiers in Immunology, 2022
Infectious diseases of the respiratory tract are one of the top causes of global morbidity and mortality with lower respiratory tract infections being the fourth leading cause of death.
Vidthiya Jeyanathan   +16 more
doaj   +1 more source

Intranasal Delivery of Liposomes to Glioblastoma by Photostimulation of the Lymphatic System

open access: yesPharmaceutics, 2022
The blood–brain barrier (BBB) limits the delivery of majority of cancer drugs and thereby complicates brain tumor treatment. The nasal-brain-lymphatic system is discussed as a pathway for brain drug delivery overcoming the BBB.
Oxana Semyachkina-Glushkovskaya   +17 more
doaj   +1 more source

Recent Developments In Brain-Targeted Drug Delivery Systems via Intranasal Route [PDF]

open access: yesFarmacja Polska, 2023
Diseases of the human nervous system such as neurological infections, Parkinson's, Alzheimer's, and other neurodegenerative diseases are severe pathological diseases and become a public health problem.
Ahmad Ainurofiq   +5 more
doaj   +1 more source

The hidden obstacles to intranasal insulin delivery: A narrative review

open access: yesJournal of Diabetology, 2023
A large number of people are suffering with one or the other type of diabetes around the globe. Insulin has proven to be beneficial for the treatment of both types of diabetes.
Ujjawal Rawat   +3 more
doaj   +1 more source

Advances and Challenges in Intranasal Delivery of Antipsychotic Agents Targeting the Central Nervous System

open access: yesFrontiers in Pharmacology, 2022
Treatment of central nervous system (CNS) disorders is challenging using conventional delivery strategies and routes of administration because of the presence of the blood–brain barrier (BBB). This BBB restricts the permeation of most of the therapeutics
Manisha Pandey   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy